Crossmark

In vitro and in silico evaluation of human serum albumin binding, blood-brain barrier permeability, and acetylcholinesterase inhibition by multi-target compounds with potential anti-Alzheimer’s disease properties

Crossref DOI link: https://doi.org/10.1007/s11696-026-04713-9

Published Online: 2026-03-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zahran, Mai

Guin-Rizzo, Adrian

Solomon, Irina

Guevara, Johnny

Pichardo-Bueno, Rosemary

Ortiz, Gabriel

Nordlander, Ebbe

Martínez, Alberto
Funding

Funding for this research was provided by:

New York City College of Technology

Professional Staff Congress and City University of New York (62067-00-50)
License Information

Text and Data Mining valid from 2026-03-07

Version of Record valid from 2026-03-07
More Information

Article History

Received: 8 December 2025

Accepted: 2 February 2026

First Online: 7 March 2026

Declarations

:

: The authors declare that they have no competing interests.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below